CAR-T Cell Therapy Market– Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032
20.18%
CAGR (2026-2032)
6.15 USD Bn.
Market Size
314
Report Pages
144
Market Tables
Overview
The CAR-T Cell Therapy Market size was valued at USD 6.15 Billion in 2025 and the total CAR-T Cell Therapy revenue is expected to grow at a CAGR of 20.18% from 2026 to 2032, reaching nearly USD 22.27 Billion.
Global CAR-T Cell Therapy Market Overview:
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is a type of cell-based gene therapy it involves altering the genes inside T cells to help them attack cancer.
Global CAR-T Cell Therapy Market Dynamics:
Rising prevalence of cancer coupled with high demand for effective treatment to cure cancer is driving the market growth.
Recent studies suggest that over 1.7 million new cancer patients are recorded in U.S. alone and nearly 4.3 million in China. A rising number of adults and children developing cancer is expected to increase demand for effective and reliable therapeutic treatment approach for the improvement of the quality of patient’s lives.
Moreover, the development of new and effective therapy options to cure symptoms of the disease is also contributing to the growth of the CAR-T cell therapy market. Increasing government initiatives for improving health care infrastructure and promoting research for cell therapy in cancer is fueling the growth of the market. In December , the National Cancer Advisory Board authorized US$ 1.8 Bn in funding for Cancer Moonshot, which is an initiative taken up to accelerate research with an aim to make more therapies available to patients with cancer. However, High costs associated with CAR-T therapy and lack of cost-effective therapies for cancer have influenced the health conditions of the population and have led to a low average life expectancy. These factors may hinder the market growth.
The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed and report has come up with recommendations for future hot spot in APAC region.
To know about the Research Methodology :- Request Free Sample Report
Global CAR-T Cell Therapy Market Segment Analysis:
The global CAR-T Cell Therapy market is segmented on the basis of Target Antigen, Therapeutic Application and End-Users. Based on Target Antigen, CD19/CD22 target antigens are estimated to hold the largest market share.
The strong growth is creditable to the high approval rate of the antigens and their commercialization. On the other hand, BCMA (B-cell maturation antigen) segment is anticipated to record a robust growth rate growth over the forecasted years. Based on Therapeutic Application, diffuse large B-cell lymphoma is expected to dominate the global market.
It accounted for xx% of the total market share in . The Multiple Myeloma (MM) segment is expected to register a significant growth rate over the forecast period.
CAR-T Cell Therapy Market Regional Insights:
North America dominated the largest CAR-T Cell Therapy Market share in 2025. North America’s market growth is attributed due to the rapid development and launch of new therapies for the treatment of cancer by key players in the market. For instance, in August , the U.S. Food and Drug Administration (FDA) approved Kymriah, a CAR-T cell therapy to treat pediatric and young adult patients suffering from a form of acute lymphoblastic leukemia. Moreover, a large patient pool suffering from cancer in the U.S. and Canada is expected to further fuel the growth of the region in the global market.
For instance, according to the Centers for Disease Control and Prevention (CDC) , around 171,000 patients with blood cancer are diagnosed each year in the U.S. Europe is expected to hold the second-largest market during the forecast period. Asia Pacific is expected to witness lucrative growth during forecast period.
Asia Pacific is expected to exhibit the highest growth over the forecast period, owing to the increasing number of global players collaborating and signing research as well as manufacturing contracts for CAR-T cell therapies with local players in the region. For instance, Cesca Therapeutics signed a license agreement with China-based, Boyalife Group, in March , for CAR-T cell-related bioprocessing, development, and manufacturing outsourcing.
The report also helps in understanding Global CAR-T Cell Therapy Market dynamics, structure by analyzing the market segments and project the Global CAR-T Cell Therapy Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global CAR-T Cell Therapy Market make the report investor’s guide.
Global CAR-T Cell Therapy Market, Key developments:
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 12 February 2026 | Novartis | The company reported positive long-term follow-up data for Kymriah® (tisagenlecleucel) in treating relapsed/refractory follicular lymphoma. | This reinforces the durability of response for Kymriah, maintaining its competitive edge in the CAR-T oncology segment. |
| 10 January 2026 | Gilead Sciences (Kite) | Kite inaugurated a new state-of-the-art automated manufacturing facility in the Netherlands dedicated to Yescarta® and Tecartus® production. | This expansion significantly increases production capacity, reducing lead times for patients across European markets. |
| 04 December 2025 | Bristol Myers Squibb | The FDA approved the expansion of Breyanzi® (lisocabtagene maraleucel) for the treatment of relapsed or refractory marginal zone lymphoma. | The approval broadens the therapeutic reach of the therapy to patients who have failed at least two prior treatment lines. |
| 18 November 2025 | Legend Biotech | The company successfully completed a major R&D milestone in their pipeline by initiating a Phase II study for a next-generation CAR-T candidate. | This advancement indicates progress toward overcoming resistance mechanisms and potentially improving patient survival rates. |
CAR-T Cell Therapy Market Ecosystem
Global CAR-T Cell Therapy Market Scope: Inquire before buying
| Global CAR-T Cell Therapy Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 6.15 USD Billion |
| Forecast Period 2026-2032 CAGR: | 20.18% | Market Size in 2032: | 22.27 USD Billion |
| Segments Covered: | by Target Antigen | CD 19/ CD 22 HER 1 BCMA Others |
|
| by Therapeutic Application | Acute Lymphocytic Leukemia Diffuse large B-cell lymphoma Chronic Lymphocytic Leukemia Hepatocellular Carcinoma Others |
||
| by Disease Indication | Leukemia Lymphoma Multiple Myeloma Others |
||
| by End-Users | Hospitals Cancer Research Institutes Clinics & Ambulatory Centers |
||
Global CAR-T Cell Therapy Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Global CAR-T Cell Therapy Market, Key Players are
1. Gilead Sciences Inc. (Kite Pharma)
2. Novartis AG
3. Bristol-Myers Squibb Company
4. Johnson & Johnson (Janssen Biotech Inc.)
5. bluebird bio Inc.
6. Gracell Biotechnologies Inc.
7. CARsgen Therapeutics HoldingsLtd.
8. Daiichi Sankyo Company Limited
9. Otsuka Pharmaceutical Co. Ltd.
10. Biocon Limited
11. Ono Pharmaceutical Co. Ltd.
12. Takeda Pharmaceutical Company Limited
13. Astellas Pharma Inc.
14. PersonGen Biomedicine (Suzhou) Co. Ltd.
15. JW Therapeutics
16. Sorrento Therapeutics Inc.
17. Sangamo Therapeutics Inc.
18. Merck & Co. Inc.
19. GSK plc
20. Eli Lilly and Company
21. Cellectis S.A.
22. Autolus Therapeutics plc
23. Adaptimmune Therapeutics plc
24. Fate Therapeutics Inc.
25. Precision BioSciences Inc.
26. Nkarta Therapeutics Inc.
27. Poseida Therapeutics Inc.
28. Allogene Therapeutics Inc.
29. Century Therapeutics Inc
30. Immuneel Therapeutics Pvt. Ltd
Others
Table of Contents
1. Global CAR-T Cell Therapy Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Global CAR-T Cell Therapy Market: Competitive Landscape
2.1. MMR Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.3.1. Company Name
2.3.2. Business Segment
2.3.3. End-user Segment
2.3.4. Revenue (2025)
2.3.5. Company Locations
2.4. Leading Global CAR-T Cell Therapy Market Companies, by market capitalization
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Global CAR-T Cell Therapy Market: Dynamics
3.1. Global CAR-T Cell Therapy Market Trends by Region
3.1.1. North America Global CAR-T Cell Therapy Market Trends
3.1.2. Europe Global CAR-T Cell Therapy Market Trends
3.1.3. Asia Pacific Global CAR-T Cell Therapy Market Trends
3.1.4. Middle East and Africa Global CAR-T Cell Therapy Market Trends
3.1.5. South America Global CAR-T Cell Therapy Market Trends
3.2. Global CAR-T Cell Therapy Market Dynamics by Region
3.2.1. North America
3.2.1.1. North America Global CAR-T Cell Therapy Market Drivers
3.2.1.2. North America Global CAR-T Cell Therapy Market Restraints
3.2.1.3. North America Global CAR-T Cell Therapy Market Opportunities
3.2.1.4. North America Global CAR-T Cell Therapy Market Challenges
3.2.2. Europe
3.2.2.1. Europe Global CAR-T Cell Therapy Market Drivers
3.2.2.2. Europe Global CAR-T Cell Therapy Market Restraints
3.2.2.3. Europe Global CAR-T Cell Therapy Market Opportunities
3.2.2.4. Europe Global CAR-T Cell Therapy Market Challenges
3.2.3. Asia Pacific
3.2.3.1. Asia Pacific Global CAR-T Cell Therapy Market Drivers
3.2.3.2. Asia Pacific Global CAR-T Cell Therapy Market Restraints
3.2.3.3. Asia Pacific Global CAR-T Cell Therapy Market Opportunities
3.2.3.4. Asia Pacific Global CAR-T Cell Therapy Market Challenges
3.2.4. Middle East and Africa
3.2.4.1. Middle East and Africa Global CAR-T Cell Therapy Market Drivers
3.2.4.2. Middle East and Africa Global CAR-T Cell Therapy Market Restraints
3.2.4.3. Middle East and Africa Global CAR-T Cell Therapy Market Opportunities
3.2.4.4. Middle East and Africa Global CAR-T Cell Therapy Market Challenges
3.2.5. South America
3.2.5.1. South America Global CAR-T Cell Therapy Market Drivers
3.2.5.2. South America Global CAR-T Cell Therapy Market Restraints
3.2.5.3. South America Global CAR-T Cell Therapy Market Opportunities
3.2.5.4. South America Global CAR-T Cell Therapy Market Challenges
3.3. PORTER's Five Forces Analysis
3.4. PESTLE Analysis
3.5. Technology Roadmap
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis For Global CAR-T Cell Therapy Industry
3.8. Analysis of Government Schemes and Initiatives For Global CAR-T Cell Therapy Industry
3.9. Global CAR-T Cell Therapy Market Trade Analysis
3.10. The Global Pandemic Impact on Global CAR-T Cell Therapy Market
4. Global CAR-T Cell Therapy Market: Global Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
4.1. Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
4.1.1. CD 19/ CD 22
4.1.2. HER 1
4.1.3. BCMA
4.1.4. Others
4.2. Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
4.2.1. Acute Lymphocytic Leukemia
4.2.2. Diffuse large B-cell lymphoma
4.2.3. Chronic Lymphocytic Leukemia
4.2.4. Hepatocellular Carcinoma
4.2.5. Others
4.3. Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
4.3.1. Leukemia
4.3.2. Lymphoma
4.3.3. Multiple Myeloma
4.3.4. Others
4.4. Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
4.4.1. Hospitals
4.4.2. Cancer Research Institutes
4.4.3. Clinics & Ambulatory Centers
4.5. Global CAR-T Cell Therapy Market Size and Forecast, by Region (2025-2032)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Global CAR-T Cell Therapy Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
5.1. North America Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
5.1.1. CD 19/ CD 22
5.1.2. HER 1
5.1.3. BCMA
5.1.4. Others
5.2. North America Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
5.2.1. Acute Lymphocytic Leukemia
5.2.2. Diffuse large B-cell lymphoma
5.2.3. Chronic Lymphocytic Leukemia
5.2.4. Hepatocellular Carcinoma
5.2.5. Others
5.3. North America Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
5.3.1. Leukemia
5.3.2. Lymphoma
5.3.3. Multiple Myeloma
5.3.4. Others
5.4. North America Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
5.4.1. Hospitals
5.4.2. Cancer Research Institutes
5.4.3. Clinics & Ambulatory Centers
5.5. North America Global CAR-T Cell Therapy Market Size and Forecast, by Country (2025-2032)
5.5.1. United States
5.5.1.1. United States Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
5.5.1.1.1. CD 19/ CD 22
5.5.1.1.2. HER 1
5.5.1.1.3. BCMA
5.5.1.1.4. Others
5.5.1.2. United States Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
5.5.1.2.1. Acute Lymphocytic Leukemia
5.5.1.2.2. Diffuse large B-cell lymphoma
5.5.1.2.3. Chronic Lymphocytic Leukemia
5.5.1.2.4. Hepatocellular Carcinoma
5.5.1.2.5. Others
5.5.1.3. United States Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
5.5.1.3.1. Leukemia
5.5.1.3.2. Lymphoma
5.5.1.3.3. Multiple Myeloma
5.5.1.3.4. Others
5.5.1.4. United States Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
5.5.1.4.1. Hospitals
5.5.1.4.2. Cancer Research Institutes
5.5.1.4.3. Clinics & Ambulatory Centers
5.5.2. Canada
5.5.2.1. Canada Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
5.5.2.1.1. CD 19/ CD 22
5.5.2.1.2. HER 1
5.5.2.1.3. BCMA
5.5.2.1.4. Others
5.5.2.2. Canada Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
5.5.2.2.1. Acute Lymphocytic Leukemia
5.5.2.2.2. Diffuse large B-cell lymphoma
5.5.2.2.3. Chronic Lymphocytic Leukemia
5.5.2.2.4. Hepatocellular Carcinoma
5.5.2.2.5. Others
5.5.2.3. Canada Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
5.5.2.3.1. Leukemia
5.5.2.3.2. Lymphoma
5.5.2.3.3. Multiple Myeloma
5.5.2.3.4. Others
5.5.2.4. Canada Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
5.5.2.4.1. Hospitals
5.5.2.4.2. Cancer Research Institutes
5.5.2.4.3. Clinics & Ambulatory Centers
5.5.3. Mexico
5.5.3.1. Mexico Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
5.5.3.1.1. CD 19/ CD 22
5.5.3.1.2. HER 1
5.5.3.1.3. BCMA
5.5.3.1.4. Others
5.5.3.2. Mexico Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
5.5.3.2.1. Acute Lymphocytic Leukemia
5.5.3.2.2. Diffuse large B-cell lymphoma
5.5.3.2.3. Chronic Lymphocytic Leukemia
5.5.3.2.4. Hepatocellular Carcinoma
5.5.3.2.5. Others
5.5.3.3. Mexico Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
5.5.3.3.1. Leukemia
5.5.3.3.2. Lymphoma
5.5.3.3.3. Multiple Myeloma
5.5.3.3.4. Others
5.5.3.4. Mexico Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
5.5.3.4.1. Hospitals
5.5.3.4.2. Cancer Research Institutes
5.5.3.4.3. Clinics & Ambulatory Centers
6. Europe Global CAR-T Cell Therapy Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
6.1. Europe Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.2. Europe Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.3. Europe Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.4. Europe Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5. Europe Global CAR-T Cell Therapy Market Size and Forecast, by Country (2025-2032)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.1.2. United Kingdom Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.1.3. United Kingdom Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.1.4. United Kingdom Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.2. France
6.5.2.1. France Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.2.2. France Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.2.3. France Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.2.4. France Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.3. Germany
6.5.3.1. Germany Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.3.2. Germany Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.3.3. Germany Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.3.4. Germany Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.4. Italy
6.5.4.1. Italy Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.4.2. Italy Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.4.3. Italy Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.4.4. Italy Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.5. Spain
6.5.5.1. Spain Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.5.2. Spain Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.5.3. Spain Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.5.4. Spain Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.6. Sweden
6.5.6.1. Sweden Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.6.2. Sweden Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.6.3. Sweden Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.6.4. Sweden Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.7. Austria
6.5.7.1. Austria Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.7.2. Austria Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.7.3. Austria Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.7.4. Austria Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
6.5.8.2. Rest of Europe Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
6.5.8.3. Rest of Europe Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
6.5.8.4. Rest of Europe Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7. Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
7.1. Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.2. Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.3. Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.4. Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5. Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Country (2025-2032)
7.5.1. China
7.5.1.1. China Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.1.2. China Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.1.3. China Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.1.4. China Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.2. S Korea
7.5.2.1. S Korea Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.2.2. S Korea Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.2.3. S Korea Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.2.4. S Korea Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.3. Japan
7.5.3.1. Japan Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.3.2. Japan Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.3.3. Japan Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.3.4. Japan Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.4. India
7.5.4.1. India Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.4.2. India Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.4.3. India Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.4.4. India Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.5. Australia
7.5.5.1. Australia Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.5.2. Australia Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.5.3. Australia Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.5.4. Australia Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.6. Indonesia
7.5.6.1. Indonesia Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.6.2. Indonesia Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.6.3. Indonesia Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.6.4. Indonesia Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.7. Malaysia
7.5.7.1. Malaysia Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.7.2. Malaysia Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.7.3. Malaysia Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.7.4. Malaysia Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.8. Vietnam
7.5.8.1. Vietnam Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.8.2. Vietnam Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.8.3. Vietnam Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.8.4. Vietnam Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.9. Taiwan
7.5.9.1. Taiwan Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.9.2. Taiwan Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.9.3. Taiwan Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.9.4. Taiwan Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
7.5.10. Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
7.5.10.2. Rest of Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
7.5.10.3. Rest of Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
7.5.10.4. Rest of Asia Pacific Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
8. Middle East and Africa Global CAR-T Cell Therapy Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
8.1. Middle East and Africa Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
8.2. Middle East and Africa Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
8.3. Middle East and Africa Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
8.4. Middle East and Africa Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
8.5. Middle East and Africa Global CAR-T Cell Therapy Market Size and Forecast, by Country (2025-2032)
8.5.1. South Africa
8.5.1.1. South Africa Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
8.5.1.2. South Africa Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
8.5.1.3. South Africa Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
8.5.1.4. South Africa Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
8.5.2. GCC
8.5.2.1. GCC Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
8.5.2.2. GCC Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
8.5.2.3. GCC Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
8.5.2.4. GCC Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
8.5.3. Nigeria
8.5.3.1. Nigeria Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
8.5.3.2. Nigeria Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
8.5.3.3. Nigeria Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
8.5.3.4. Nigeria Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
8.5.4. Rest of ME&A
8.5.4.1. Rest of ME&A Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
8.5.4.2. Rest of ME&A Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
8.5.4.3. Rest of ME&A Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
8.5.4.4. Rest of ME&A Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
9. South America Global CAR-T Cell Therapy Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
9.1. South America Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
9.2. South America Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
9.3. South America Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
9.4. South America Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
9.5. South America Global CAR-T Cell Therapy Market Size and Forecast, by Country (2025-2032)
9.5.1. Brazil
9.5.1.1. Brazil Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
9.5.1.2. Brazil Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
9.5.1.3. Brazil Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
9.5.1.4. Brazil Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
9.5.2. Argentina
9.5.2.1. Argentina Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
9.5.2.2. Argentina Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
9.5.2.3. Argentina Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
9.5.2.4. Argentina Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
9.5.3. Rest Of South America
9.5.3.1. Rest Of South America Global CAR-T Cell Therapy Market Size and Forecast, by Target Antigen (2025-2032)
9.5.3.2. Rest Of South America Global CAR-T Cell Therapy Market Size and Forecast, by Therapeutic Application (2025-2032)
9.5.3.3. Rest Of South America Global CAR-T Cell Therapy Market Size and Forecast, by Disease Indication (2025-2032)
9.5.3.4. Rest Of South America Global CAR-T Cell Therapy Market Size and Forecast, by End-Users (2025-2032)
10. Company Profile: Key Players
10.1. Gilead Sciences Inc. (Kite Pharma)
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Scale of Operation (small, medium, and large)
10.1.7. Details on Partnership
10.1.8. Regulatory Accreditations and Certifications Received by Them
10.1.9. Awards Received by the Firm
10.1.10. Recent Developments
10.2. Novartis AG
10.3. Bristol-Myers Squibb Company
10.4. Johnson & Johnson (Janssen Biotech Inc.)
10.5. bluebird bio Inc.
10.6. Gracell Biotechnologies Inc.
10.7. CARsgen Therapeutics HoldingsLtd.
10.8. Daiichi Sankyo Company Limited
10.9. Otsuka Pharmaceutical Co. Ltd.
10.10. Biocon Limited
10.11. Ono Pharmaceutical Co. Ltd.
10.12. Takeda Pharmaceutical Company Limited
10.13. Astellas Pharma Inc.
10.14. PersonGen Biomedicine (Suzhou) Co. Ltd.
10.15. JW Therapeutics
10.16. Sorrento Therapeutics Inc.
10.17. Sangamo Therapeutics Inc.
10.18. Merck & Co. Inc.
10.19. GSK plc
10.20. Eli Lilly and Company
10.21. Cellectis S.A.
10.22. Autolus Therapeutics plc
10.23. Adaptimmune Therapeutics plc
10.24. Fate Therapeutics Inc.
10.25. Precision BioSciences Inc.
10.26. Nkarta Therapeutics Inc.
10.27. Poseida Therapeutics Inc.
10.28. Allogene Therapeutics Inc.
10.29. Century Therapeutics Inc
10.30. Immuneel Therapeutics Pvt. Ltd
11. Key Findings
12. Industry Recommendations
13. Global CAR-T Cell Therapy Market: Research Methodology
14. Terms and Glossary